All In Biotech

Drug Trial Radar · NCT05191563

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

An Open-Label, Randomized, Single-Dose Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Jan 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

56

Actual

Start

Jul 31, 2021

Primary completion

Sep 12, 2021

Study completion Sep 12, 2021

Sponsor

Sponsor type
Industry
First posted
Jan 13, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

An Open-Label, Randomized, Single-Dose Crossover Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects

Conditions

  • Healthy

Interventions

  • HCP1904-1Drug

    Take it once per period.

  • RLD2006Drug

    Take it once per period.

  • RLD2001-2Drug

    Take it once per period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax of LosartanTime frame: Day 1, Day 15: pre-dose(0 hour)~48hours
  2. AUClast of LosartanTime frame: Day 1, Day 15: pre-dose(0 hour)~48hours
  3. Cmax of EXP3174Time frame: Day 1, Day 15: pre-dose(0 hour)~48hours
  4. AUClast of EXP3174Time frame: Day 1, Day 15: pre-dose(0 hour)~48hours
  5. Cmax of ChlorthalidoneTime frame: Day 1, Day 15: pre-dose(0 hour)~144hours
  6. AUClast of ChlorthalidoneTime frame: Day 1, Day 15:pre-dose(0 hour)~144hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Yangji Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.